IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.672
NA - Nord America 1.353
AS - Asia 1.340
SA - Sud America 370
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 4.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.279
RU - Federazione Russa 903
CN - Cina 453
SG - Singapore 408
BR - Brasile 305
IT - Italia 246
SE - Svezia 203
VN - Vietnam 178
HK - Hong Kong 145
DE - Germania 88
FR - Francia 61
CA - Canada 42
IN - India 39
FI - Finlandia 37
GB - Regno Unito 35
BD - Bangladesh 26
PL - Polonia 24
AR - Argentina 23
MX - Messico 22
NL - Olanda 20
EC - Ecuador 19
ZA - Sudafrica 19
JP - Giappone 17
ES - Italia 14
TR - Turchia 12
AT - Austria 10
IE - Irlanda 10
IQ - Iraq 9
CO - Colombia 7
ID - Indonesia 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
UZ - Uzbekistan 6
JO - Giordania 5
MA - Marocco 5
MY - Malesia 5
PH - Filippine 5
UA - Ucraina 5
CL - Cile 4
PK - Pakistan 4
SA - Arabia Saudita 4
AU - Australia 3
CM - Camerun 3
EG - Egitto 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A1 - Anonimo 2
BE - Belgio 2
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
JM - Giamaica 2
KR - Corea 2
NP - Nepal 2
RS - Serbia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.783
Salva come PNG Salva come JPEG
Città #
Dallas 281
Ashburn 213
Singapore 210
Moscow 201
Hong Kong 143
San Jose 119
Milan 112
Beijing 91
Shanghai 88
Ho Chi Minh City 76
New York 61
Hefei 52
Los Angeles 44
Lauterbourg 42
Princeton 39
Lawrence 38
São Paulo 35
Hanoi 28
Helsinki 26
Munich 26
Rome 24
Santa Clara 24
Brescia 22
Warsaw 19
Montreal 16
Falkenstein 15
Nuremberg 15
Orem 15
Stockholm 15
Atlanta 14
Chennai 14
Denver 14
Johannesburg 14
Tokyo 14
Council Bluffs 12
Haiphong 12
Brooklyn 11
Cesano Boscone 11
The Dalles 11
Toronto 11
Dublin 10
Frankfurt am Main 10
Amsterdam 9
Boston 9
Poplar 9
Belo Horizonte 8
Bologna 8
Guangzhou 8
Porto Alegre 8
Turin 8
Houston 7
Rio de Janeiro 7
Vienna 7
Chicago 6
Guayaquil 6
Lappeenranta 6
London 6
Washington 6
Boardman 5
Columbus 5
Manaus 5
Mexico City 5
Salvador 5
Shenzhen 5
Tashkent 5
Tianjin 5
Amman 4
Ancona 4
Ankara 4
Barnet 4
Campinas 4
Caxias do Sul 4
Curitiba 4
Florianópolis 4
Hangzhou 4
Hải Dương 4
Kuala Lumpur 4
Manchester 4
Naples 4
New Delhi 4
Phoenix 4
Pune 4
Quito 4
Riyadh 4
San Francisco 4
Seattle 4
Sorocaba 4
South San Francisco 4
Turku 4
Antakya 3
Baghdad 3
Bergamo 3
Biên Hòa 3
Bogotá 3
Brasília 3
Busto Arsizio 3
Bắc Ninh 3
Calgary 3
Changsha 3
Charlotte 3
Totale 2.531
Salva come PNG Salva come JPEG
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 183
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 164
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 140
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 135
The interferon landscape along the respiratory tract impacts the severity of COVID-19 133
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 130
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 128
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 127
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 127
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 123
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 122
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 121
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 119
Bacteriophages and Their Immunological Applications against Infectious Threats 107
The initial interplay between HIV and mucosal innate immunity 105
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 103
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 102
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 101
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 100
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 99
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 99
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 98
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 96
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 94
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 93
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 92
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 88
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 86
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 85
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 85
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 83
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 82
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 82
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 81
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 81
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 79
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 78
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 78
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 76
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 74
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 74
Role and potential therapeutic use of antibodies against herpetic infections 73
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 69
Viral Respiratory Pathogens and Lung Injury 69
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 65
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 57
Phage Therapy: An Alternative to Antibiotics 48
Next Generation Vaccines for Infectious Diseases 47
Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise 46
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 45
An Exploratory Survey on the Use of Anal Cytology as a Tool for Anal Cancer Screening in Italy 7
Long-Term Stability Bio-Reconfigurable Differential Impedance Electronic Platform for Virus Diagnostic 5
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccination 1
null 1
Totale 4.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 6 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024315 1 20 42 62 19 62 9 25 13 8 18 36
2024/2025892 81 20 13 35 33 94 158 170 90 63 58 77
2025/20263.239 233 279 373 423 305 96 259 229 779 136 69 58
Totale 4.954